Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
13.8
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter21 May 2026 to 20 August 2026ConsolidatedJapanese GAAPNet Sales159,042¥ millionYear on year +13.8%Progress 24.9%
Operating profit8,424¥ millionYear on year +16.0%Progress 26.3%
Ordinary income8,568¥ millionYear on year +17.6%Progress 27.8%
Net income attributable to owners of the parent6,866¥ millionYear on year +36.4%Progress 36.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥72.30
Financial position at period-end
Total assets406,449¥ million
of which net assets 145,040 ¥ millionEquity ratio 35.7%vs. prior year-end +1.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Regional sales¥67,372 million (YoY +17.1%), ¥13,092 million (YoY +14.1%), ¥33,890 million (YoY +3.0%), ¥23,191 million (YoY +4.4%), ¥13,923 million (YoY +10.1%), ¥7,571 million (YoY +152.9%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥640,000 million (YoY +12.9%)
Operating profit¥32,000 million (YoY +18.1%)
Ordinary income¥30,800 million (YoY +11.1%)
Net income¥19,000 million (YoY +10.9%)
Revision to Earnings ForecastNo
Annual Dividend Forecast¥56 → ¥64
Factors Behind Changes in Business Performance
Expansion of the food category through a higher proportion of large-store openings, improved expertise in handling fresh food, development of stores offering one-stop shopping under the “food and drug” format, and the opening of 21 drugstores and 20 co-located pharmacies together with the densification of the store network
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Impairment lossNo recognition
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥1 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥0 million
Depreciation and amortization¥3,890 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End95,616,980
Treasury Shares at Period-End653,913
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 21 May 2026 to 20 August 2026 |
| Net Sales | ¥159,042 million (YoY +13.8%) |
| Operating profit | ¥8,424 million (YoY +16.0%) |
| Ordinary income | ¥8,568 million (YoY +17.6%) |
| Profit attributable to owners of the parent | ¥6,866 million (YoY +36.4%) |
| Net income per share | ¥72.30 |
| Equity ratio | End of the current fiscal period 35.7 / End of previous period 34.3 |
| Total assets | ¥406,449 million |
| Net assets | ¥145,040 million |
| Full-year earnings forecast | Net Sales ¥640,000 million (YoY +12.9%) / Operating profit ¥32,000 million (YoY +18.1%) / Ordinary income ¥30,800 million (YoY +11.1%) / Net income ¥19,000 million (YoY +10.9%) |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | ¥56 → ¥64 |
| Regional sales | ¥67,372 million (YoY +17.1%), ¥13,092 million (YoY +14.1%), ¥33,890 million (YoY +3.0%), ¥23,191 million (YoY +4.4%), ¥13,923 million (YoY +10.1%), ¥7,571 million (YoY +152.9%) |
| Depreciation and amortization | ¥3,890 million |
| Impairment loss | No recognition |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥1 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥0 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 95,616,980 |
| Treasury Shares at Period-End | 653,913 |
| Factors Behind Changes in Business Performance | Expansion of the food category through a higher proportion of large-store openings, improved expertise in handling fresh food, development of stores offering one-stop shopping under the “food and drug” format, and the opening of 21 drugstores and 20 co-located pharmacies together with the densification of the store network |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicySegment revenueSegment profitOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company expanded its food category by increasing the proportion of large-store openings, improved its expertise in handling fresh food, and developed stores offering one-stop shopping under the “food and drug” format. It opened 21 drugstores and 20 co-located pharmacies and promoted the densification of its store network.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.